Advanced search
Publication Cover
OncoTargets and Therapy Volume 14, 2021 - Issue
Submit an article Journal homepage
115
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2− Advanced Breast Cancer: A Nationwide Real-World Experience

Katalin Boér1 Department of Medical Oncology, Szent Margit Hospital, Budapest, HungaryORCID Iconhttps://orcid.org/0000-0002-5101-7289View further author information
ORCID Icon,
Gábor Rubovszky2 Chemotherapy Department B, National Institute of Oncology, Budapest, Hungary;3 Department of Internal Medicine and Oncology, Semmelweis University, Faculty of Medicine, Budapest, HungaryView further author information
,
György Rokszin4 RxTarget Ltd., Szolnok, HungaryView further author information
,
Zsolt Abonyi-Tóth4 RxTarget Ltd., Szolnok, Hungary;5 University of Veterinary Medicine, Budapest, HungaryView further author information
,
Csenge Földesi6 Pfizer Ltd., Budapest, HungaryView further author information
&
Magdolna Dank3 Department of Internal Medicine and Oncology, Semmelweis University, Faculty of Medicine, Budapest, HungaryCorrespondence[email protected]
View further author information
Pages 3971-3981 | Published online: 01 Jul 2021

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.